These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3385425)

  • 41. Developmental effects of alpha-fluoromethylhistidine, an irreversible inhibitor of histidine decarboxylase, on growth and on levels and turnover of catecholamines.
    Slotkin TA; Bartolome J; Whitmore WL
    Life Sci; 1983 Nov; 33(21):2137-45. PubMed ID: 6645794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of acute and chronic treatment with an atypical antidepressant drug, nomifensine, on the sleep-wake activity in rats.
    Lelkes Z; Obál F; Benedek G; Rubicsek G; Alföldi P; Obál F
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):149-53. PubMed ID: 3561528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of adenosine and 2'-deoxycoformycin on sleep and wakefulness in rats.
    Virus RM; Djuricic-Nedelson M; Radulovacki M; Green RD
    Neuropharmacology; 1983 Dec; 22(12A):1401-4. PubMed ID: 6607425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FMH-induced decrease in central histamine levels produces increased feeding and body weight in rats.
    Orthen-Gambill N; Salomon M
    Physiol Behav; 1992 Apr; 51(4):891-3. PubMed ID: 1594690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of lighting conditions on sleep and wakefulness in albino Lewis and pigmented Brown Norway rats.
    Benca RM; Gilliland MA; Obermeyer WH
    Sleep; 1998 Aug; 21(5):451-60. PubMed ID: 9703584
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bromocriptine, dihydroergotoxine and sleep in rats: effects of repeated administration.
    Radulovacki M; Brodie M; Walovitch R; Yanik G
    Gerontology; 1981; 27(3):152-7. PubMed ID: 7239174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term depletion of brain histamine induced by alpha-fluoromethylhistidine increases feeding-associated locomotor activity in mice with a modulation of brain amino acid levels.
    Sakai N; Sakurai E; Onodera K; Sakurai E; Asada H; Miura Y; Watanabe T
    Behav Brain Res; 1995 Dec; 72(1-2):83-8. PubMed ID: 8788860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of a GABA(B) receptor antagonist on the sleep-waking cycle in the rat.
    Gauthier P; Arnaud C; Gandolfo G; Gottesmann C
    Brain Res; 1997 Oct; 773(1-2):8-14. PubMed ID: 9409699
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous behavior and sleep-wakefulness cycle in isolated and paired REM sleep deprived-marihuana treated rats.
    Monti JM; Carlini EA
    Pharmacol Biochem Behav; 1975; 3(6):1025-9. PubMed ID: 177995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects on sleep of melanin-concentrating hormone (MCH) microinjections into the dorsal raphe nucleus.
    Lagos P; Torterolo P; Jantos H; Chase MH; Monti JM
    Brain Res; 2009 Apr; 1265():103-10. PubMed ID: 19230831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of inactivation of mammalian L-histidine decarboxylase by (S)-alpha-fluoromethylhistidine.
    Kubota H; Hayashi H; Watanabe T; Taguchi Y; Wada H
    Biochem Pharmacol; 1984 Apr; 33(7):983-90. PubMed ID: 6712729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Positive allosteric modulation of mGlu7 receptors by AMN082 affects sleep and wakefulness in the rat.
    Cavas M; Scesa G; Navarro JF
    Pharmacol Biochem Behav; 2013 Feb; 103(4):756-63. PubMed ID: 23262401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Study of the 5-HT2 antagonist ritanserin on sleep-walking cycle in the rat.
    Silhol S; Glin L; Gottesmann C
    Pharmacol Biochem Behav; 1992 Jan; 41(1):241-3. PubMed ID: 1539075
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of intraventricular implantation of crystalline estradiol benzoate on the sleep-wakefulness circadian rhythm of ovariectomized rats.
    Matsushima M; Takeichi M
    Jpn J Psychiatry Neurol; 1990 Mar; 44(1):111-21. PubMed ID: 2362386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in sleep and wakefulness following single and repeated exposures to toluene vapor in rats.
    Arito H; Tsuruta H; Oguri M
    Arch Toxicol; 1988 Aug; 62(1):76-80. PubMed ID: 3190461
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of timiperone, a new antipsychotic drug, on the sleep-wakefulness cycle in cats.
    Tanaka M; Kojima H; Akashi A
    Jpn J Pharmacol; 1985 Nov; 39(3):391-4. PubMed ID: 2869168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of a derivative of 1,5 benzodiazepine on sleep].
    Ayala-Guerrero F; Vargas-Reyna L; Taboada J; Martínez R; Cortés E
    Gac Med Mex; 1990; 126(6):519-22. PubMed ID: 1983306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single administration of metyrapone modifies sleep-wake patterns in the rat.
    Drouet JB; Rousset C; Maury R; Michel V; Buguet A; Cespuglio R; Canini F
    Eur J Pharmacol; 2011 Feb; 652(1-3):60-4. PubMed ID: 21114995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of selective neuronal nitric oxide synthase inhibition on sleep and wakefulness in the rat.
    Cavas M; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):56-67. PubMed ID: 16023276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sleep and waking in 5,7-DHT-lesioned or (-)-pindolol-pretreated rats after administration of buspirone, ipsapirone, or gepirone.
    Monti JM; Jantos H; Silveira R; Reyes-Parada M; Scorza C
    Pharmacol Biochem Behav; 1995 Oct; 52(2):305-12. PubMed ID: 8577795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.